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The effect of bradykinin on changes in the chemical levels of myo-inositol 
polyphosphates in renal papillary collecting tubules was investigam. 
w-inositol phosphate mass was determined by means of an enzymatic, 
fluorometric assay. Bradykinin induced increases in mya-inositol mono-, bis-, 
and trisphosphate which were both time and concentration dependent. 
Furthermore, the magnitude of the chemical levels of w-inositol 
monophosphate formed were unlikely to be accounted for solely by the formation 
and degradation of myo-inositol trisphosphate. These observations are 
consistent with the concomitant hydrolysis of phosphatidylinositol and 
phosphatidylinositol bisphosphate. This study also confirms, in freshly 
isolated renal tubules, observations regarding bradykinin-induced phosphatidyl- 
inositol bisphosphate hydrolysis made previously in radiolabeled cultures. 
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Renal papillary collecting tubule cells comprise the most distal portion 
of the mammalian nephron and, therefore, play an important role in defining 
the final composition of urine. However, the detailed biological 
responsiveness of this tissue remains poorly understood. Previous studies 
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have documented a close association between bradykinin binding, w-inositol 
trisphosphate labeling, calcium mobilization, and prostaglandin E2 
formation (1,2). In these studies myo-[2-3H]inositol labeled cultures 
demonstrated increased activity in IPI, IP2, and IP3 in the presence of 
bradykinin which occurred in a time and concentration-dependent manner. In a 
subsequent study, myo-inositol 1,2 cyclic monophosphate was also shown to 
increase in a similar manner and over a time course consistent with 
phosphatidylinositol hydrolysis (3). These studies, as do others of a similar 
design, assume when tissues are labeled to isotopic equilibrium that changes 
in radioactivity represent true changes in mass. This assumption has not been 
tested since to do so requires minimally the ability to measure inositol 
phosphate mass. A further observation in these studies was that [3H]IP3 
formation appeared to precede C3H]IPI, 13HlIP2, and [3H]inositol 
1,2 cyclic monophosphate formation. It could not be ascertained, however, 
whether the increased labeling of IPI and IP2 represented degradation of 
IP3 or was the result of the phosphodiesteratic hydrolysis of both 
phosphatidylinositol and phosphatidylinositol bisphosphate. Finally, because 
these cells were cultured for 3 to 5 days prior to investigation and because 
they were depleted of w-inositol to promote the incorporation of radiolabel, 
it was unclear whether the kinetics of inositol phosphate formation reflected 
the true in vivo responsiveness. -- 
To address these concerns, a recently developed assay for the 
determination of mya-inositol phosphate mass (4) was utilized to measure the 
hormonal responsiveness of freshly isolated rabbit renal papillary collecting 
tubule cells. 
MATERIALS AND METHODS 
Renal papillary collecting tubule cells were harvested from male 
New Zealand white rabbits as previously described (1). In brief, animals were 
anesthetized with pentobarbital, the kidneys were harvested, and the renal 
papillae were resected. Tissue from three animals was pooled and digested in 
Krebs buffer containing collagenase (1.0 mg percent) at 370C for 2 hours. 
Thereafter, the digestate was filtered and exposed to hypotonic buffer 
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(100 mosm) for 3 minutes. Tubular fragments were pelleted and resuspended in 
oxygenated Krebs buffer. 
45 ~1 aliquots of tubular suspension, representing 150 to 400 pg cell 
protein, were then placed in 1.5 ml microfuge tubes. 5 ~1 of buffer or of 
bradykinin (lo-6M for time course determinations) in buffer was added to the 
side of the microfuge tube and gently mixed with the tubular suspension at the 
initiation of the incubation period. To terminate the incubation, 200 ~1 of 
ice-cold trichloroacetic acid (1 M) was added, and the precipitated protein 
was pelleted by centrifugation. The supernatant was removed for inositol 
phosphate determination as described below. The cellular protein was 
resuspended in 200 ~1 of 0.62 N NaOH and assayed tiith the fluorescamine 
reagent (5). 
The determination of w-inositol phosphate mass is based on the enzymatic 
measurement of myo-inositol as described by MacGregor and Matschinsky (6) as 
recently described (4). Because the application of their method to the 
measurement of inositol phosphates has yet to be published, it is described in 
detail below. The trichloroacetic acid from the supernatants was extracted by 
the addition of 1 ml of water-saturated diethyl ether and removal of the upper 
phase. This was repeated five times or until the pH of the aqueous phase was 
greater than 5. 
650C for 20 min. 
The residual ether was removed by heating the sample to 
The sample was applied to 0.75 x 12 cm columns of Dowex 
AG l- x8 formate anion exchange resin (bed volume 1 ml). M o-inositol and the 
inositol phosphates were serially eluted with water (16 ml ; -f 0.025 M ammonium 
formate (8 ml); 0.2 M ammonium formate, 0.1 M formic acid (8 ml); 0.4 M 
ammonium formate, 0.1 M formic acid (8 ml); and 0.75 M ammonium formate, 0.1 M 
formic acid (8 ml). These buffers eluted respectively w-inositol, 
glycero-phosphatidyl inositol, IPl, IP2, and IP3. 
Pooled elutions containing either IPl, IP2 or IP3 from the separated 
samples were desalted and neutralized by dilution with 50 ml of water and by 
addition to a 0.75 x 12 cm column containing Dowex AG l- x8, chloride form 
(bed volume 2 ml); this was followed by the addition of 25 ml of water. The 
respective inositol phosphates were eluted with 1.5 M LiCl (8 ml). Samples 
were brought to dryness in a vacuum centrifuge (Speed Vat, Savant 
Instruments). Trapped water was removed by resuspension of the lithium salts 
in 4 ml of anhydrous ethanol with reevaporation. The dried pellet, containing 
LiCl and the lithium salt of the inositol phosphate was resuspended in 8 ml of 
absolute ethanol. The remaining salt was pelleted by centrifugation and the 
supernatant removed. This latter step was repeated until only a trace of 
pellet remained, usually 3 to 4 times. 
Samples were reconstituted in 100 ~1 of Tris buffer (50 mM, pH 9.0) and 
dephosphorylated with 50 U/ml of bovine intestinal alkaline phosphatase at 
370C for 2 hours. These conditions have been demonstrated to 
dephosphorylate greater than 95 percent of the total inositol phosphates. The 
enzyme was inactivated by heating the samples for 3 minutes in a boiling water 
bath. 
The liberated myo-inositol was chemically assayed by the protocol of 
MacGregor and Matschinsky (6). The following modifications were made. The 
ass:y was adapted to assay between 1 and 10 pmoles of free w-inositol. 
NAD was excluded from the first malate oxidation step since sufficient 
NAD+ was found to remain following myo-inositol oxidation. Only 7 mM 
oxaloacetate was used in the myo-inositol oxidation step. Assays were 
initially performed in 6 x 50 mm test tubes utilizing samples adjusted to 
10 ~1 and w-inositol dehydrogenase reagent adjusted to 2 ~1. Residual 
oxaloacetate was destroyed with 0.5 ~1 of H202, and residual NAD+ was 
eliminated by the addition of 5 ~1 of 0.35 N NaOH. The first malate oxidation 
was performed with 10 ~1 of reagent. Amplification was performed by cycling 
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5 Pl of the incubation mixture following the protocol of Kato et al. (7). -- 
100 Pl of cycling reagent was utilized. Enzymes were adjusted to cycle 
1000 times. Fluorescence was measured in a Farrand ratio fluorometer 
following the addition of 1 ml of malate indicator reagent. 
The recovery of the inositol phosphates varied between 75 and 90 percent 
and was assessed by the addition of radiolabeled standards following the 
addition of trichloroacetic acid. Samples were assayed in triplicate and 
tissue blanks in duplicate. Several blanks were determined throughout the 
course of each assay including duplicate tissue blanks (exluding myo-inositol 
dehydrogenase) for each sample, a reagent blank (excluding sample and 
myo-inositol dehydrogenase), a cycling blank, and a standard blank. With the 
exception of the tissue blanks, these were usually less than 10 percent of the 
fluorescence observed for 10 pmoles of myo-inositol standard and always less 
than 30 percent of this fluorescence. Unknown levels of myo-inositol were 
determined on aliquots of dephosphorylated samples varying between 1 to 10 ~1 
and diluted to 10 Pl with water by comparison to known standards measured in 
triplicate. Samples which did not fall within the standard curve were 
repeated following adjustments in sample size. 
All materials were obtained from Sigma Chemical Co. (St. Louis, MO) with 
the exception of malate dehydrogenase which was obtained from 
Boerhinger-Mannheim (Indianapolis, IN) and Dowex resins which were supplied by 
Biorad (Richmond, CA). 
RESULTS AND DISCUSSION - 
Under the incubation and assay conditions employed, inositol phosphate 
mass in renal papillary collecting tubule cells increased rapidly following 
exposure to bradykinin. Basal levels of IP1, IP2, and IP3 were 891, 83 
and 124 pmoleslmg protein; these rose to maximal levels of 1953, 245 and 
319 pmoleslmg protein respectively (Table I). Of note is the later time at 
TABLE I. TIME DEPENDENT MYO-INOSITOL PHOSPHATE FORMATION - 
TIME CONTROL BRADYKININ 
(set) 10 300 10 30 60 300 
lP1 891 l 236 793 * 140 989 * 345 1273 * 424 1226 * 425 1953 * 683* 
IP2 83.0 * 16.4 90.4 * 12.9 107 * 49.5 181 * 41.0** 111 l 22.0 245 f 78.0** 
IP3 124 * 23.0 135 l 13.4 142 l 14.1 191 l 17.6** 319 l 42.0** 244 * 84.5* 
Q-inositol phosphate formation in response to bradykinin (10m7M). Papillary 
collecting tubule cells were incubated as described in the Methods section. Data 
represents the mean l SEM from 5-6 determinations. * p c 0.05; ** p < 0.01 by 
unpaired t analysis. 
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which the inositol phosphates attained maximal concentrations as opposed to 
the previous radiolabeling studies. In those studies IP3 peaked by 15 to 
30 seconds and approached baseline by 1 to 2 minutes. On the one hand, this 
may reflect the less efficient mixing of effector and tissue in the present 
study. On the other hand, the inositol phosphates measured by radiolabeling 
in the prior study may not have been at equal specific activity in spite of 
the fact that the tissue was at isotopic equilibrium. 
The level of IP3 is comparable to that reported previously in platelets 
utilizing gas chromatographic analysis of w--inositol (8) and to other 
tissues as reported recently by Meek (9). In this latter study the recovery 
of myo-inositol trisphosphate was found to be highly variable depending on the 
tissue studied and extraction conditions employed. Preliminary observations 
in cortical brain slices utilizing the current methodology have confirmed th 
observed variability (Shayman, JA and Agranoff, BW, unpublished observations 




accumulating within the first 5 minutes of kinin stimulation is in 
excess of that which could reasonably be accounted for by the formation and 
subsequent degradation of IP3. In the present study the integrated mass of 
IPI and IP2 produced was 5.5 times that of IP3. Thus, unless the rates 
of production and metabolism of IP3 were significantly greater than the 
dephosphorylation of IPI and IP2, it is likely that there exists 
concomitant hydrolysis of both phosphatidylinositol and phosphatidylinositol 
bisphosphate. This observation supports those of Wilson et al. (10) in -- 
thrombin-stimulated platelets. In that study measurements of the specific 
activity of the inositol containing phospholipids were consistent with the 
concurrent hydrolysis of both phosphatidylinositol and phosphatidylinositol 
both 
bisphosphate. However, a more rigorous demonstration of concurrent 
phosphatidylinositol and phosphatidylinositol bisphosphate hydrolysis in 
platelets and renal epithelia will require measurements of true specific 
activity in myo-[2-3H]inositol labeled tissues. This should now be poss 
with the existing methodology. 
ble 
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Figure 1. Concentration dependent rise in w-inositol trisphosphate in 
response to lo-7M bradykinin. Freshly isolated renal tubules 
were stimulated as described in Methods. Points represent the mean 
of three experiments in duplicate * SEM. 
Figure 1 displays the concentration dependence of IP3 formation in 
response to bradykinin. The effective concentration yielding 50 percent of 
the maximal formation of IP3 was lo-I'M. This is consistent with previous 
observations of both prostaglandin E2 formation and intracellular calcium 
mobilization utilizing Quin 2 (1,2). These data also confirm the role of 
bradykinin in stimulating phosphatidylinositol bisphosphate hydrolysis as 
previously observed in radiolabeling studies. 
In summary, a newly developed method for the measurement of inositol 
phosphate mass has been applied to distal renal epithelial cells. The present 
study demonstrates the utility of this methodology for measuring inositol 
phosphates in freshly isolated tissues and represents the first documentation 
of changes in inositol phosphate mass in non-transformed renal epithelia. 
Moreover, it demonstrates that kinin stimulation of renal papillary collecting 
tubule cells results in the formation of chemical levels of IP1 and IP3 
which are consistent with the concurrent hydrolysis of phosphatidylinositol 
and phosphatidylinositol bisphosphate but not with hydrolysis of 
phosphatidylinositol bisphosphate alone. 
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